Harnessing the orthogonality of fluorine for advanced biomaterials and biotechnologies - perfluorination imparts unique, abiotic properties to molecules and materials
Active Project Grant Awarded Last action
- Award ID
- R35GM156610
- Recipient
-
University Of California, LOS Angeles UEI RN64EPNH8JC6
- Awarding agency
-
National Institute of General Medical Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $937,744
Award facts
- Assistance listing
- 93.859 Biomedical Research and Research Training
- Completion date 30% complete
- Place of performance
- Los Angeles, CA 90095, USA
Award details come from USAspending.gov.
Description
The unifying goal of our work is exploiting these properties to enhance therapeutics, diagnostics, and create new chemical tools. In one approach, we capitalize on the inverse quadrapole moment imparted by perfluorination of aromatics. We design cyclophane host molecules that can recognize perfluorinated aromatic compounds in living systems through arene-perfluoroarene interactions as well as secondary non-covalent or covalent interactions. Ultimately, we aim to apply these novel host-guest complexes to the detection and/or treatment of diseases with a metabolic signature, such as cancer, inflammation, and drug-resistant infection. A different area employs perfluoroalkyl compounds, more commonly referred to as perfluorocarbons, which phase separate from aqueous and organic solution. The perfluorocarbons can be stabilized as droplets in water by using surfactant to create perfluorocarbon nanoemulsions. We view perfluorocarbon nanoemulsions as bioorthogonal, nano, reaction vessels and develop methods to load an array of payloads, control their biodistribution, and trigger their disassembly. The major goal of this work is to create a versatile nanomaterial scaffold that can be tailored toward many different diseases in a personalized manner. Additionally, we continue our fruitful collaboration with the camp ÀS group who have developed the first methods to measure mechanical forces in tissue by capitalizing on the orthogonality of perfluorocarbons. This method involves the microinjection of a droplet of perfluorocarbon containing a surfactant and fluorophore. The surfactant controls the interfacial tension of the droplet and the fluorophore allows for visualization by confocal microscopy. As the cells exert forces on the droplet, the droplet deforms. The deformation can be observed by microscopy and, if the interfacial tension is known, correlated back to forces. We employ our expertise in fluorous fluorophore and amphiphile synthesis to create custom components for the droplet measurements, expanding the range of forces and scope of animals in which these measurements can be performed.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $468,872 | |
| Original award | $468,872 |
Quick answers
Who received award R35GM156610?
R35GM156610 was awarded to University Of California, LOS Angeles by National Institute of General Medical Sciences (National Institutes of Health) on May 1, 2025.
How much is award R35GM156610 worth?
$937,744 has been obligated on R35GM156610.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award